CDKN1B Loss Fuels ER Therapy Resistance in Breast Cancer
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
In the relentless quest to conquer breast cancer, researchers at the Sylvester Comprehensive Cancer Center, part of the University of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine